JERSEY
CITY, N.J., Jan. 31,
2024 /PRNewswire/ -- WallachBeth Capital LLC, a
leading provider of capital markets and institutional execution
services, announced today that 60 Degrees Pharmaceuticals, Inc.,
("60P," NASDAQ: SXTP; SXTPW) specialists in developing and
marketing medicines for infectious diseases, has completed its
previously announced Public Offering of 5,260,901 units (the
"Units") at a price to the public of $0.385 per Unit and 999,076 pre‑funded units (the
"Pre‑Funded Units") at a price to the public of $0.375 per Pre‑Funded Unit.
The underwriters were granted an option, exercisable within 45
days after the closing of the offering, to purchase shares of 60P's
common stock at a price of $0.385 per
share and/or Warrants at a price of $0.01 per Warrant and/or Pre-Funded Warrants at a
price of $0.375 per Pre-Funded
Warrant, or any combination of additional shares of common stock,
Warrants and/or Pre-Funded Warrants, representing, in the
aggregate, up to 15% of the number of Units sold in the offering,
15% of the Warrants underlying the Units and Pre-Funded Units sold
in the offering and 15% of the Pre-Funded Warrants underlying the
Pre-Funded Units sold in the offering, in all cases less the
underwriting discount to cover over-allotments, if any. On
January 31, 2024, WallachBeth Capital
LLC partially exercised its over-allotment option with respect to
818,177 Warrants.
WallachBeth Capital LLC is the Sole Bookrunner for the
offering.
The offering was made pursuant to 60P's registration statement
on Form S‑1 (File No. 333‑276641) previously filed with the
Securities and Exchange Commission ("SEC") and declared effective
by the SEC on January 29, 2024. A
final prospectus relating to the offering was filed with the SEC on
January 31, 2024, and is available on
the SEC's website at www.sec.gov. Electronic copies of the final
prospectus relating to the offering, when available, may be
obtained from WallachBeth Capital, LLC, via email:
cap‑mkts@wallachbeth.com, or by calling +1 (646) 237‑8585, or by
standard mail at WallachBeth Capital LLC, Attn: Capital Markets,
185 Hudson St., Suite 1410, Jersey City,
NJ 07311, USA.
About WallachBeth Capital LLC
WallachBeth Capital offers a robust range of capital markets and
investment banking services to the healthcare community. The firm's
experience includes initial public offerings, follow-on issues,
PIPE offerings, and private transactions. The firm's website is
located at www.wallachbeth.com.
This news release does not constitute an offer to sell or a
solicitation of an offer to buy the securities described herein,
nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or
jurisdiction.
Forward-Looking Statements
This press release may include forward-looking statements,
including statements of future expectations regarding the business
and offering of 60P's units. Forward-looking statements can be
identified by words such as "believes," "expects," "estimates,"
"intends," "may," "plans," "will" and similar expressions, or the
negative of these words. Such forward-looking statements are based
on facts and conditions as they exist at the time such statements
are made and predictions as to future facts and conditions. Readers
of this press release are cautioned not to place undue reliance on
any forward-looking statements. We undertake no obligation to
update any forward-looking statement relating to matters discussed
in this press release, except as may be required by applicable
securities laws.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/wallachbeth-capital-announce-closing-of-60-degrees-pharmaceuticals-2-4-million-public-offering-302049501.html
SOURCE WallachBeth Capital LLC